HomeBBN • SWX
Bellevue Group AG
CHF 14.50
Ene 15, 6:10:02 AM GMT+1 · CHF · SWX · Disclaimer
StockSegurong nakalista sa CH
Nakaraang pagsara
CHF 14.75
Sakop ng araw
CHF 14.50 - CHF 14.80
Sakop ng taon
CHF 11.05 - CHF 24.30
Market cap
195.19M CHF
Average na Volume
9.95K
P/E ratio
13.08
Dividend yield
7.93%
Primary exchange
SWX
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(CHF)Hun 2024Y/Y na pagbabago
Kita
18.41M-11.31%
Gastos sa pagpapatakbo
13.73M-10.56%
Net na kita
3.72M-7.22%
Net profit margin
20.184.61%
Kita sa bawat share
EBITDA
Aktuwal na % ng binabayarang buwis
17.26%
Kabuuang asset
Kabuuang sagutin
(CHF)Hun 2024Y/Y na pagbabago
Cash at mga panandaliang investment
30.49M100.63%
Kabuuang asset
138.75M-4.69%
Kabuuang sagutin
22.05M-24.81%
Kabuuang equity
116.70M
Natitirang share
13.20M
Presyo para makapag-book
1.67
Return on assets
10.71%
Return on capital
Net change in cash
(CHF)Hun 2024Y/Y na pagbabago
Net na kita
3.72M-7.22%
Cash mula sa mga operasyon
3.65M137.31%
Cash mula sa pag-invest
Cash mula sa financing
-8.10M45.85%
Net change in cash
-4.17M83.13%
Malayang cash flow
Tungkol
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021. Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
Itinatag
1993
Mga Empleyado
88
Tumuklas pa
Maaaring interesado ka sa
Nabuo ang listahang ito mula sa mga paghahanap kamakailan lang, mga sinubaybayang security, at iba pang aktibidad. Alamin pa

“As is” na ibinibigay ang lahat ng data para lang sa mga layunin sa personal na impormasyon, at hindi inilaan na maging payong pinansyal, ni hindi rin ito para sa mga layunin sa trading o investment, buwis, legal, accounting, o iba pang payo. Hindi tagapayo sa investment ang Google, ni hindi rin ito pinansyal na tagapayo at walang inihahayag na pananaw, rekomendasyon, o opinyon patungkol sa anumang kumpanyang kasama sa listahang ito o sa anumang seguridad na inisyu ng mga kumpanyang iyon. Konsultahin ang iyong broker o pampinansyal na kinatawan para ma-verify ang presyo bago magsagawa ng anumang trade. Matuto pa
Naghanap din ang mga tao ng
Search
I-clear ang paghahanap
Isara ang paghahanap
Mga app ng Google
Pangunahing menu